YpsoLoop™: The prefilled autoinjector uniting sustainability and patient convenience

YpsoLoop® resolves the long-standing conflict between patient convenience and environmental responsibility. Single-use autoinjectors have been associated with high levels of branded waste and C02 emissions, raising concerns for healthcare providers, patients and pharmaceutical partners. YpsoLoop® ends this trade-off by combining the proven simplicity of a two-step, pre-filled device with a design that advances sustainability in two ways: by already lowering CO₂ emissions through adherence to ecodesign principles, and by being built for circularity.

Independent life-cycle assessments show YpsoLoop® delivers up to 87% lower material-related CO2 emissions than conventional injectors. Its cradle-to-gate footprint is about 18 g CO2-eq per device, achieved through smart material choices and streamlined architecture. This impact is already realized, regardless of any future take-back or recycling programs.

The platform is built from two recyclable mono-material subassemblies, designed for high-volume automated disassembly and efficient material recovery. This makes it ready for closed-loop recycling as soon as take-back systems are in place.

YpsoLoop® also advances usability. ClickGuide® provides continuous acoustic cues during injection, extending intuitive holding time and reducing the risk of incomplete injections. An ergonomic cap for easy grip, a clear dose window, and a needle-concealing design support confidence and adherence across diverse patient groups.

For pharmaceutical partners, YpsoLoop® integrates seamlessly into existing YpsoMate® fill-finish and final-assembly infrastructure, protecting prior investments while aligning with rising ESG expectations.

By uniting circular sustainability with patient-centric usability, YpsoLoop® sets a new benchmark for pre-filled autoinjectors. It enables pharma to address climate impact and waste while maintaining operational efficiency and enhancing the patient experience.